Characterization of the novel HLA‐C*16:98:02 allele by sequencing‐based typing
HLA · 2024
DOI: 10.1111/tan.15285 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Lucie Blandin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility and Immunogenetics laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: HLA-C Antigens, Genes, MHC Class I. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐C*16:98:02 differs from HLA‐C*16:98:01 by one nucleotide substitution in codon 132 in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Histocompatibility and Immunogenetics laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
- Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, 146 rue Léo Saignat, Bordeaux, France.
- EA7453 CHELTER, Clermont-Auvergne University, Clermont-Ferrand, France.
ORCID-Profile: Jonathan Visentin, Paul Rouzaire
Zitieren
APA
Blandin, L., Visentin, J., Duclaut, M., Lemal, R., & Rouzaire, P. (2024). Characterization of the novel HLA‐C*16:98:02 allele by sequencing‐based typing. HLA. https://doi.org/10.1111/tan.15285
Vancouver
Blandin L, Visentin J, Duclaut M, Lemal R, Rouzaire P. Characterization of the novel HLA‐C*16:98:02 allele by sequencing‐based typing. HLA. 2024. doi:10.1111/tan.15285
BibTeX
@article{Blandin2024,
author = {Blandin, Lucie and Visentin, Jonathan and Duclaut, Marion and Lemal, Richard and Rouzaire, Paul},
title = {Characterization of the novel HLA‐C*16:98:02 allele by sequencing‐based typing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15285}
}
EUVIMED